This announcement is a separate document:
Oberon Uranium Corp: AUDITED ANNUAL FINANCIAL STATEMENTS EN
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
17:00
Fosun Pharma: The new indication approval for Surulitinib injection has been granted.
Shanghai Fosun Pharmaceutical-0.19%
16:58
Sinopec Corp: On December 3, spent 10.4458 million Hong Kong dollars to repurchase 2.5 million shares.
SINOPEC CORP+1.44%
16:58
Zheshang has been approved to become the major shareholder of Guodu Securities.
Zheshang+1.41%